诚意药业：诚意小贷和颜晓玲拟合计减持公司股份不超过约388万股

Group 1 - The controlling shareholder of Chengyi Pharmaceutical, Mr. Yan Yiyi, holds approximately 77.19 million shares, accounting for 23.58% of the total share capital [1] - Chengyi Small Loan Co., a concerted actor of Mr. Yan, holds about 3.53 million shares, representing 1.08% of the total share capital [1] - Another concerted actor, Ms. Yan Xiaoling, holds approximately 350,000 shares, which is 0.11% of the current total shares [1] Group 2 - Chengyi Small Loan and Ms. Yan Xiaoling plan to reduce their holdings by a total of up to approximately 3.88 million shares, which is 1.18% of the total share capital, within three months after 15 trading days from the announcement date [1] - The reduction will be executed through centralized bidding or block trading, with the price determined by the market price at the time of the reduction [1] - Any corporate actions that affect the total share capital, such as stock dividends or capital reserve transfers, will lead to adjustments in the planned reduction of shares [1] Group 3 - For the fiscal year 2024, Chengyi Pharmaceutical's revenue composition is 99.71% from the pharmaceutical manufacturing industry and 0.29% from other businesses [1] - As of the report date, Chengyi Pharmaceutical has a market capitalization of 4.4 billion yuan [1]